Mersana Therapeutics Depreciation & Amortization 2011-2026 | MRSN

Annual Depreciation & Amortization Mersana Therapeutics

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
1.63 M	1.52 M	927 K	855 K	1.01 M	1.24 M	1.26 M	928 K	655 K	297 K	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.63 M	297 K	1.03 M

Quarterly Depreciation & Amortization Mersana Therapeutics

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	316 K	-	-	-	423 K	-	-	-	319 K	-	645 K	432 K	205 K	-	644 K	432 K	226 K	-	750 K	494 K	248 K	-	963 K	653 K	337 K	-	907 K	565 K	258 K	-	673 K	438 K	209 K	-	449 K	265 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
963 K	205 K	472 K

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
AbCellera Biologics ABCL	18.4 M	$ 3.54	-0.7 %	$ 1.06 B	Canada
Acorda Therapeutics ACOR	31.7 M	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	7 K	-	4.01 %	$ 150 M	Canada
Advaxis ADXS	369 K	-	-9.65 %	$ 45.9 M	USA
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
AgeX Therapeutics AGE	131 K	-	-10.17 %	$ 12.2 K	USA
Albireo Pharma ALBO	274 K	-	-0.23 %	$ 916 M	USA
Aileron Therapeutics ALRN	63 K	-	10.36 %	$ 9.8 M	USA
Aptorum Group Limited APM	1.13 M	$ 0.8	1.81 %	$ 4.36 M	China
Adverum Biotechnologies ADVM	3.65 M	-	-	$ 86.2 M	USA
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
Applied Molecular Transport AMTI	3.13 M	-	-	$ 10.1 M	USA
Atea Pharmaceuticals AVIR	416 K	$ 6.15	1.57 %	$ 501 M	USA
Arcturus Therapeutics Holdings ARCT	3.02 M	$ 6.62	-0.15 %	$ 181 M	Israel
BioCardia BCDA	84 K	$ 1.35	6.29 %	$ 28.6 M	USA
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
Athersys ATHX	1.43 M	-	3.77 %	$ 22.4 M	USA
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
Acer Therapeutics ACER	66 K	-	2.71 %	$ 14 M	USA
ARCA biopharma ABIO	27 K	-	1052.0 %	$ 415 M	USA
Allena Pharmaceuticals ALNA	363 K	-	3.16 %	$ 1.9 M	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
AlloVir ALVR	398 K	-	4.14 %	$ 49.1 M	USA
Can-Fite BioPharma Ltd. CANF	14 K	$ 3.58	-0.28 %	$ 7.79 B	Israel
Catalyst Biosciences CBIO	2.48 M	$ 11.29	-2.51 %	$ 1.01 B	USA
Anika Therapeutics ANIK	6.43 M	$ 14.58	1.53 %	$ 214 M	USA
Aptinyx APTX	122 K	-	-39.0 %	$ 4.57 M	USA
Aptose Biosciences APTO	32 K	-	-45.71 %	$ 1.2 M	Canada
CNS Pharmaceuticals CNSP	3.31 K	$ 2.32	-5.51 %	$ 887 K	USA
AVEO Pharmaceuticals AVEO	67 K	-	-	$ 521 M	USA
Ayala Pharmaceuticals AYLA	162 K	-	-	$ 7.46 M	Israel
Aytu BioScience AYTU	5.38 M	$ 2.69	1.7 %	$ 16.9 M	USA
Curis CRIS	203 K	$ 0.89	3.74 %	$ 5.61 M	USA
Autolus Therapeutics plc AUTL	7.55 M	$ 1.51	-0.33 %	$ 385 M	Britain
Athira Pharma ATHA	970 K	-	-	$ 269 M	USA